Pancreatic Cancer Research

ResearcherRutgers, The State University of New JerseyActive in the last 2 years

Henry Anthony Pitt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-0745-3341; OpenAlex author ID A5112286850. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
53
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 3 papers

Papers 13

  1. Impact of Neoadjuvant Therapy for Pancreatic Cancer: Transatlantic Trend and Postoperative Outcomes Analysis. Last author DOI 10.1097/xcs.0000000000000971↗
  2. Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Eval… Co-author DOI 10.1245/s10434-024-15932-3↗
  3. ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Pa… Co-author DOI 10.1245/s10434-024-16021-1↗
  4. Neoadjuvant Therapy for Pancreatic Cancer: Increased Use and Improved Optimal Outcomes. Last author DOI 10.1097/xcs.0000000000000095↗
  5. Ethnic and racial disparities of pancreatic adenocarcinoma in Florida. Co-author DOI 10.1016/j.hpb.2019.09.013↗
  6. Biliary microbiome in pancreatic cancer: alterations with neoadjuvant therapy. Last author DOI 10.1016/j.hpb.2019.04.005↗
  7. Laparoscopic distal pancreatectomy for pancreatic cancer is safe and effective. Co-author DOI 10.1007/s00464-017-5633-7↗
  8. Reduced morbidity with minimally invasive distal pancreatectomy for pancreatic adenocarcinoma. Last author DOI 10.1016/j.hpb.2017.01.014↗
  9. Adipocytes enhance murine pancreatic cancer growth via a hepatocyte growth factor (HGF)-mediated mechanism. Co-author DOI 10.1016/j.ijsu.2016.03.002↗
  10. Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates? Last author DOI 10.1007/s11605-014-2620-3↗
  11. National assessment of margin status as a quality indicator after pancreatic cancer surgery. Co-author DOI 10.1245/s10434-013-3338-2↗
  12. Obesity, but not high-fat diet, promotes murine pancreatic cancer growth. Co-author DOI 10.1007/s11605-012-1931-5↗
  13. Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma? Co-author DOI 10.1016/j.surg.2011.07.048↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bodil Andersson · 3 shared papers, 2024 · strength 0.48
  2. Karin U. Johansen · 3 shared papers, 2024 · strength 0.48
  3. Tobias Keck · 3 shared papers, 2024 · strength 0.48
  4. Bergþór Björnsson · 3 shared papers, 2024 · strength 0.48
  5. Simone Augustinus · 3 shared papers, 2024 · strength 0.48
  6. Bobby Tingstedt · 3 shared papers, 2024 · strength 0.48
  7. Ulrich Friedrich Wellner · 3 shared papers, 2024 · strength 0.48
  8. Marc G. Besselink · 3 shared papers, 2024 · strength 0.48
  9. Michael Garrett House · 4 shared papers, 2011–2024 · strength 0.42
  10. Matthew H. G. Katz · 3 shared papers, 2015–2024 · strength 0.36
  11. Catherine H. Davis · 2 shared papers, 2022–2024 · strength 0.32
  12. Joal D. Beane · 2 shared papers, 2022–2024 · strength 0.32
  13. Michael B. Ghadimi · 2 shared papers, 2024 · strength 0.31
  14. Izaak Quintus Molenaar · 2 shared papers, 2024 · strength 0.31
  15. Susan van Dieren · 2 shared papers, 2024 · strength 0.31
  16. Tara M. Mackay · 2 shared papers, 2024 · strength 0.31
  17. Waldemar H. Uhl · 2 shared papers, 2024 · strength 0.31
  18. Poya Ghorbani · 2 shared papers, 2024 · strength 0.31
  19. Thomas F. Stoop · 2 shared papers, 2024 · strength 0.31
  20. Roeland F. de Wilde · 2 shared papers, 2024 · strength 0.31
  21. Christopher Lee Wolfgang · 2 shared papers, 2024 · strength 0.31
  22. Marco Del Chiaro · 2 shared papers, 2024 · strength 0.31
  23. J. Sven D. Mieog · 2 shared papers, 2024 · strength 0.31
  24. Martijn W.J. Stommel · 2 shared papers, 2024 · strength 0.31
  25. Nicholas Joseph Zyromski · 4 shared papers, 2011–2018 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.